Randomized trial reveals lower incidence of preterm preeclampsia with low-dose aspirin in high-risk pregnancies, indicating a preventive benefit.
Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).
No takes yet. Share an insight, caveat, or question.
Rolnik et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: